YSS Slides 2018 March
PDF renditions of the powerpoint presentations can be viewed and downloaded from this page by clicking the specific point on the program. The program itself can be viewed and downloaded by clicking here.
Program details of the EBF 4th YSS
The BioA Brain Embracing New Ideas
| Friday 16 March 2018 | ||
| 09:00 | 10:20 | Session 1: Alternative sampling having an impact |
| 09:00 | 09:05 | Laura Mercolini (University of Bologna) |
| Introduction to the session | ||
| 09:05 | 09:20 | Sofie Velghe (University of Ghent) |
| Volumetric absorptive microsampling as an alternative tool for therapeutic drug monitoring of first-generation anti-epileptic drugs. | ||
| 09:20 | 09:35 | Michele Protti (University of Bologna) |
| Enhanced stability and detection window of large and small molecules prohibited in sports by urine microsampling | ||
| 09:35 | 09:50 | Bas Sleumer (PRA Health Sciences) not released for publication |
| Orexin 2: M16 and M12 – the bold and the beautiful! – Determination of a drug and metabolite M16 and M12 in rat plasma using capillary micro sampling and LC-MS/MS | ||
| 09:50 | 10:05 | Lisa Delahaye (University of Ghent) not released for publication |
| Volumetric absorptive microsampling for the combined determination of paracetamol and its cysteine adduct | ||
| 10:05 | 10:20 | Neus Fabregat Cabello (University of Liège) |
| Dealing with small sample volumes and analyte levels: the case of vitamin D metabolites in aqueous humor | ||
| 10:20 | 10:40 | Poster pitch (2-minute poster pitch for posters entering the 2018 YSS Best Poster competition – participation is voluntary for each poster submission) |
| 10:40 | 11:30 | Coffee break and Poster Viewing |
| . | ||
| 11:30 | 12:30 | Session 2: Overcoming Bioanalytical issues |
| 11:30 | 11:45 | Natalie Corden (LGC) not released for publication |
| The Development of a 7 Analyte Method for Measuring Heroin Metabolites in Human Urine by LC-MS/MS | ||
| 11:45 | 12:00 | Snezhana Traykova (Comac Medical Ltd) |
| Overcoming extraction challenges of a bisphosphonate drug from human plasma utilizing an LLE with phase separation approach | ||
| 12:00 | 12:15 | Toon Babylon (UCB Biopharma) not released for publication |
| Bridging a classic serum PK assay to Cerebrospinal Fluid: challenges in using surrogate matrices and semi-automation during assay development and validation | ||
| 12:15 | 12:30 | Barbara Marsiglia (Envigo) not released for publication |
| Development of a LC-MS/MS bioanalytical method for the quantitation of fragrances in plasma: challenges and troubleshooting in view of validation | ||
| 12:30 | 13:30 | Lunch break |
| 13:30 | 14:30 | Session 3: MMM – Matrices, Molecules and Methods/part 1 |
| 13:30 | 13:45 | Jörg Faber (A&M Labor GmbH) |
| Best practices for the bioanalysis of endogenous substances | ||
| 13:45 | 14:00 | Nanda Gruben (PRA Health Sciences) not released for publication |
| Validation of an ultrasensitive Single Molecule Counting Immunoassay for determination of pharmacokinetics in a regulated environment | ||
| 14:00 | 14:15 | Estelle Cochet (Novimmune SA) not released for publication |
| Validation of Biomarker Assays in Disease Populations: Case Study of an Inflammatory Cytokine Immunoassay in Rheumatoid Arthritis (RA) | ||
| 14:15 | 14:30 | Nikunj Tanna (Waters Corporation) not released for publication |
| Applying small molecule workflows to large molecule assays – Quantification of IGF-I from biological matrices using LC-MS. | ||
| 14:30 | 15:00 | Tea break and announcement 2018 YSS Best Poster Prize |
| 15:00 | 16:00 | Session 4: MMM – Matrices, Molecules and Methods/part 2 |
| 15:00 | 15:15 | Serge Desmoulins (Agilent Technologies) not released for publication |
| Drug-to-Antibody Ratio Determination for Antibody-Drug Conjugates in Serum Enbaled by a Sample Preparation Platform that Automates Affinity Purification and Deglycosylation | ||
| 15:15 | 15:30 | Dan Baker (University of Hertfordshire) not released for publication |
| Solid Phase MicroExtraction (SPME): towards in vivo sampling of tissues and organs | ||
| 15:30 | 15:45 | Maria Jadhav (Novartis AG) not released for publication |
| Balancing neutralizing antibodies assay sensitivity and drug tolerance in the cell-based systems | ||
| 15:45 | 16:00 | Sandy Rigot (UCB Biopharma) |
| Hybrid immunocapture-LC-MS/MS as a powerful and challenging tool to overcome selectivity issues | ||
| 16:00 | 16:10 | Closing Remarks and Adjourn |
